Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Prentice

Showing results (281-290 of 299) with videos related to

Pageof 30
Sort By:
Bone Marrow Transplantation|July 1, 1991
Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remissionM J Gilmore, M D Hamon, H G Prentice, et al.
The Journal of Infectious Diseases|September 28, 2001
Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplantsG Aubert, A F Hassan-Walker, J A Madrigal, et al.
Leukemia|October 27, 1997
Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment responseL Foroni, L A Coyle, M Papaioannou, et al.
Haematologica|June 22, 2001
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patientsP Gameiro, S Vieira, P Carrara, et al.
Leukemia|April 18, 2002
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemiaM S Jabber Al-Obaidi, M Martineau, C F Bennett, et al.
Annals of Internal Medicine|November 30, 1999
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project GroupH J Kolb, G Socié, T Duell, et al.
British Journal of Haematology|October 23, 1997
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patientsH G Prentice, I M Hann, R Herbrecht, et al.
Bone Marrow Transplantation|April 16, 1998
Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infectious Diseases Working Party of the EBMTP Ljungman, C Cordonnier, H Einsele, et al.
Lancet (London, England)|December 15, 1979
Parenteral acyclovir therapy for herpesvirus infections in manP J Selby, R L Powles, B Janeson, et al.
Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.
Pageof 30

Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
Bone Marrow Transplantation|July 1, 1991
Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remissionM J Gilmore, M D Hamon, H G Prentice, et al.
The Journal of Infectious Diseases|September 28, 2001
Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplantsG Aubert, A F Hassan-Walker, J A Madrigal, et al.
Leukemia|October 27, 1997
Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment responseL Foroni, L A Coyle, M Papaioannou, et al.
Haematologica|June 22, 2001
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patientsP Gameiro, S Vieira, P Carrara, et al.
Leukemia|April 18, 2002
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemiaM S Jabber Al-Obaidi, M Martineau, C F Bennett, et al.
Annals of Internal Medicine|November 30, 1999
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project GroupH J Kolb, G Socié, T Duell, et al.
British Journal of Haematology|October 23, 1997
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patientsH G Prentice, I M Hann, R Herbrecht, et al.
Bone Marrow Transplantation|April 16, 1998
Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infectious Diseases Working Party of the EBMTP Ljungman, C Cordonnier, H Einsele, et al.
Lancet (London, England)|December 15, 1979
Parenteral acyclovir therapy for herpesvirus infections in manP J Selby, R L Powles, B Janeson, et al.
Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.
Pageof 30